Serum biomarker panels for the diagnosis of gastric adenocarcinoma

British Journal of Cancer

Volumn 106, Issue 4, 2012, Pages 733-739

  Ahn, H S ^a   Shin, Y S ^b   Park, P J ^b   Kang, K N ^b   Kim, Y ^c   Lee, H J ^b   Yang, H K ^b   Kim, C W ^b  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

biomarker; diagnosis; gastric adenocarcinoma; screening

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; DICKKOPF 3 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HEMOGLOBIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREALBUMIN; PROAPOLIPOPROTEIN A1; PROSTATE SPECIFIC ANTIGEN; RANTES; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VITAMIN D BINDING PROTEIN; VITRONECTIN;

ADULT; ARTICLE; CLASSIFICATION ALGORITHM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEOMICS; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; AGED; ALGORITHMS; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VALIDATION STUDIES AS TOPIC;

EID: 84863135365     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.592     Document Type: Article

References (44)

1. Abraham N, Barkun A, Larocque M, Fallone C, Mayrand S, Baffis V, Cohen A, Daly D, Daoud H, Joseph L (2002) Predicting which patients can undergo upper endoscopy comfortably without conscious sedation. Gastrointest Endosc 56: 180-189
2. Amin A, Gilmour H, Graham L, Paterson-Brown S, Terrace J, Crofts TJ (2002) Gastric adenocarcinoma missed at endoscopy. J R Coll Surg Edinb 47: 681-684 (Pubitemid 35414828)
3. Bramble MG, Suvakovic Z, Hungin AP (2000) Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy. Gut 46: 464-467 (Pubitemid 30305808)
4. Breiman L (2001) Random forest. Machine Learning 45: 5-32
5. Bustamante M, Devesa F, Borghol A, Ortuño J, Ferrando MJ (2002) Accuracy of the initial endoscopic diagnosis in the discrimination of gastric ulcers: Is endoscopic follow-up study always needed? J Clin Gastroenterol 35: 25-28 (Pubitemid 34663346)
6. Dossat N, Mange A, Solassol J, Jacot W, Lhermitte L, Maudelonde T, Daures JP, Molinari N (2007) Comparison of supervised classification methods for protein profiling in cancer diagnosis. Cancer Inform 3: 295-305
7. Forones NM, Mandowsky SV, Lourenco LG (2001) Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate to tumor progression in gastric cancer. Hepatogastroenterology 48: 1199-1201 (Pubitemid 32757776)
8. Froehlich F, Schwizer W, Thorens J, Kohler M, Gonvers JJ, Fried M (1995) Conscious sedation for gastroscopy: Patient tolerance and cardiorespiratory parameters. Gastroenterology 108: 697-704
9. Furey TS, Cristianini N, Duffy N, Bednarski DW, Schummer M, Haussler D (2000) Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 16: 906-914
10. Gaspar MJ, Arribas I, Coca MC, Diez-Alonso M (2001) Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma. Tumour Biol 22: 318-322 (Pubitemid 32823950)
11. Genta RM (2004) Screening for gastric cancer: Does it make sense? Aliment Pharmacol Ther 20(Suppl 2): 42-47 (Pubitemid 39237527)
12. Gotoda T (2007) Endoscopic resection of early gastric cancer. Gastric Cancer 10: 1-11 (Pubitemid 46356261)
13. Ikeguchi M, Hatada T, Yamamoto M, Miyake T, Matsunaga T, Fukumoto Y, Yamada Y, Fukuda K, Saito H, Tatebe S (2009) Serum interleukin-6 and-10 levels in patients with gastric cancer. Gastric Cancer 12: 95-100
14. Ishigami S, Natsugoe S, Hokita S, Che X, Tokuda K, Nakajo A, Iwashige H, Tokushige M, Watanabe T, Takao S, Aikou T (2001) Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol 32: 41-44 (Pubitemid 32038110)
15. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96 (Pubitemid 351521864)
16. Juhasz M, Ebert MP, Schulz HU, Rocken C, Molnar B, Tulassay Z, Malfertheiner P (2003) Dual role of serum soluble E-cadherin as a biological marker of metastatic development in gastric cancer. Scand J Gastroenterol 38: 850-855 (Pubitemid 37011579)
17. Kim BK, Lee JW, Park PJ, Shin YS, Lee WY, Lee KA, Ye S, Hyun H, Kang KN, Yeo D, Kim Y, Ohn SY, Noh DY, Kim CW (2009a) The multiplex bead array approach to identifying serum biomarkers associated with breast cancer. Breast Cancer Res 11: R22
18. Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA, Kim BG, Kim SG, Kim SH, Jang JS, Kim MC, Kim KH, Han JY, Kim HJ (2009b) Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer 9: 155
19. Kodama I, Koufuji K, Kawabata S, Tetsu S, Tsuji Y, Takeda J, Kakegawa T (1995) The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA. Int Surg 80: 45-48
20. Kong SH, Park DJ, Lee HJ, Jung HC, Lee KU, Choe KJ, Yang HK (2004) Clinicopathologic features of asymptomatic gastric adenocarcinoma patients in Korea. Jpn J Clin Oncol 34: 1-7 (Pubitemid 43115328)
21. Lee HJ, Yang HK, Ahn YO (2002) Gastric cancer in Korea. Gastric Cancer 5: 177-182
22. Liang Y, Fang M, Li J, Liu CB, Rudd JA, Kung HF, Yew DT (2006) Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry. Exp Mol Pathol 81: 176-180 (Pubitemid 44780734)
23. Lim JY, Cho JY, Paik YH, Chang YS, Kim HG (2007) Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Int J Biol Markers 22: 281-286 (Pubitemid 351256264)
24. Maniatis AG, Eisen GM, Brazer SR (1997) Endoscopic discrimination of gastric ulcers. J Clin Gastroenterol 24: 203-206 (Pubitemid 27310587)
25. Marrelli D, Pinto E, De Stefano A, Farnetani M, Garosi L, Roviello F (2001) Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. Am J Surg 181: 16-19 (Pubitemid 32209115)
26. Marrelli D, Roviello F, De Stefano A, Farnetani M, Garosi L, Messano A, Pinto E (1999) Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 57: 55-62 (Pubitemid 29308672)
27. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y (2003) Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 98: 735-739 (Pubitemid 36576295)
28. Ministry of Health and Welfare (2003) Annual Report of the Korea Central Cancer Registry 2001
29. Nakata B, Chung KH, Kato Y, Yamashita Y, Inui A, Arimoto Y, Maeda K, Onoda N, Sawada T, Sowa M (1998) Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer. Br J Cancer 77: 1820-1824 (Pubitemid 28254617)
30. Nolen BM, Marks JR, Ta'san S, Rand A, Luong TM, Wang Y, Blackwell K, Lokshin AE (2008) Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer. Breast Cancer Res 10: R45
31. Ohno S, Inagawa H, Dhar DK, Fujii T, Ueda S, Tachibana M, Suzuki N, Inoue M, Soma G, Nagasue N (2003) The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. Anticancer Res 23: 5015-5022 (Pubitemid 38182119)
32. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108 (Pubitemid 40372904)
33. Patz Jr EF, Campa MJ, Gottlin EB, Kusmartseva I, Guan XR, Herndon II JE (2007) Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 25: 5578-5583
34. Raftopoulos SC, Segarajasingam DS, Burke V, Ee HC, Yusoff IF (2010) A cohort study of missed and new cancers after esophagogastroduodenoscopy. Am J Gastroenterol 105: 1292-1297
35. Reiter W, Stieber P, Reuter C, Nagel D, Cramer C, Pahl H, Fateh-Moghadam A (1997) Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma. Anticancer Res 17: 2903-2906 (Pubitemid 27434816)
36. Ren H, Du N, Liu G, Hu HT, Tian W, Deng ZP, Shi JS (2006) Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation. World J Gastroenterol 12: 2789-2792 (Pubitemid 43796495)
37. Soblin LH, Wittekind CH (eds) (2002) TNM Classification of Malignant Tumors, 6th edn. Wiley-Liss: New York The R project of statistical computing [http://www.rproject.org]
38. Ueland FR, Desimone CP, Leigh S, Ware RA, Goodrich S, Podzielinski I, Smith A, Santoso JT, Nagell J, Zhang Z (2010) The OVA1 test improves the preoperative assessment of ovarian tumors. Gynecol Oncol 116: S23
39. Vapnik V (1995) The Nature of Statistical Learning Theory. Springer-Verlag: New York
40. Voutilainen ME, Juhola MT (2005) Evaluation of the diagnostic accuracy of gastroscopy to detect gastric tumours: Clinicopathological features and prognosis of patients with gastric cancer missed on endoscopy. Eur J Gastroenterol Hepatol 17: 1345-1349 (Pubitemid 41830456)
41. Wu CW, Wang SR, Chao MF, Wu TC, Lui WY, P0Eng F K, Chi CW (1996) Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol 91: 1417-1422 (Pubitemid 26236381)
42. Yalamarthi S, Witherspoon P, McCole D, Auld CD (2004) Missed diagnoses in patients with upper gastrointestinal cancers. Endoscopy 36: 874-879 (Pubitemid 39307137)
43. Yuan A, Chen JJ, Yang PC (2008) Pathophysiology of tumor-associated macrophages. Adv Clin Chem 45: 199-223
44. Yurkovetsky Z, Skates S, Lomakin A, Nolen B, Pulsipher T, Modugno F, Marks J, Godwin A, Gorelik E, Jacobs I, Menon U, Lu K, Badgwell D, Bast Jr RC, Lokshin AE (2010) Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol 28: 2159-2166